Work

Efficacy and safety of regorafenib combined with immune checkpoint inhibitors in advanced hepatocellular carcinoma patients progressing after lenvatinib treatment.

Year: 2025
Type: article
Study design: Observational Study
Language: English
Subfield: Hepatology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4410815713
FWCI:
Cites:
Cited by:
Related to: 10